RK

Ramesh Kantaria

Active Director Director DIN 11229137
DIN 11229137 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramesh Kantaria

Data last updated:

Ramesh Kantaria is a Director at Outlast Research Private Limited (since 2025) and Director at R3s Foods And Wellness Private Limited (since 2025).

DIN 11229137
Primary Designation Director
First Appointment 05 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Outlast Research Private Limited U21009MH2025PTC456051
Director03 Sep 20252025Active
Director05 Aug 20252025Active

Board colleagues of Ramesh Kantaria

Directorship timeline

Open interactive timeline →
Outlast Research Private Limited
R3s Foods And Wellness Private Limited
Premium access

Shareholding and investment profile for Ramesh Kantaria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Kantaria

Ramesh Kantaria currently holds 2 directorships: Outlast Research Private Limited (Director, since 03 Sep 2025); R3s Foods And Wellness Private Limited (Director, since 05 Aug 2025).

Ramesh Kantaria was first appointed on 05 Aug 2025 as Director at R3s Foods And Wellness Private Limited.

The current boards of Ramesh Kantaria's companies include Parth Dhanjibhai Suthar (Outlast Research Private Limited), Shweta Kantaria (R3s Foods And Wellness Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available